EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Potential Health Risks and Benefits of Progesterone in the Transgender Woman Population—A Narrative Review

Simone Szymczyk iD, Katarzyna Mączka iD, Lidia Mądrzak, Monika Grymowicz iD, Roman Smolarczyk

Journal of Clinical Medicine · 12.11.2024 · 13 (22) · 6795

DOI: 10.3390/jcm13226795 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.11.2024. Verfasst von Simone Szymczyk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecological Endocrinology, Clinical Hospital of Duchess Anna Mazowiecka, Medical University of Warsaw, 2 Karowa Street, 00-315 Warsaw…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Currently, progesterone is notably absent from conventional feminizing hormone therapies for transgender women. Anecdotal reports indicate the potential for health advantages following the incorporation of progesterone into treatment regimens. The primarily female hormone, progesterone naturally surges in women during the menstrual luteal phase. When administered exogenously, it may expedite bodily changes that are pivotal for gender transition. Progesterone holds promise as a potential remedy for various health conditions prevalent in the transgender woman population.

Methods

This narrative review synthesizes existing literature and presents a comprehensive account of the administration of exogenous progesterone in transgender women. A literature search was conducted using the PubMed, Embase, ScienceDirect, and ResearchGate databases. The following keywords were used in the search: progesterone, transgender, breast neoplasms, lactation, prostate, testicular neoplasms, and thrombosis. These terms were combined using Boolean operators. The results of the initial search were screened by three independent reviewers based on their relevance to the topic under study.

Results

A total of 104 studies were initially identified as meeting the criteria for inclusion. Following an assessment based on the contents of the title, abstract, and full text, 39 studies were deemed eligible for inclusion. A critical examination of health outcomes was conducted across key sections, including breast development, mental health, lactation, cancer risk (breast and prostate), thrombosis, and nervous and other systems.

Discussion

The use of progesterone in the transgender woman population is a topic that has yet to be sufficiently researched. The limited sample size, short follow-up periods, and lack of randomization restrict the potential for achieving a robust scientific evidence base. In order to gain a fuller understanding of this topic, findings from studies on contraception, hormone replacement therapy, and animal models were considered.

Conclusions

Progesterone may have a beneficial effect on the bodies of transgender women without significant adverse health effects. Further investigation through well-designed studies is recommended. Randomized controlled trials that include various dosages, broad and long-term effects, and precise demographics are needed. There is an immediate need for more knowledge to create appropriate patent and clinical practice guidelines.

Schlagwörter

Stichwörter der Autor:innen

GAHTMTFfeminizationhormoneprogesteronetranstransgender

Autor:innen und Institutionen

  • Department of Gynecological Endocrinology, Clinical Hospital of Duchess Anna Mazowiecka, Medical University of Warsaw, 2 Karowa Street, 00-315 Warsaw, Poland.
  • Doctoral School, Medical University of Warsaw, 02-091 Warsaw, Poland.

ORCID-Profile: Simone Szymczyk, Katarzyna Mączka, Monika Grymowicz

Zitieren

APA

Szymczyk, S., Mączka, K., Mądrzak, L., Grymowicz, M., & Smolarczyk, R. (2024). The Potential Health Risks and Benefits of Progesterone in the Transgender Woman Population—A Narrative Review. Journal of Clinical Medicine, 13(22), 6795. https://doi.org/10.3390/jcm13226795

Vancouver

Szymczyk S, Mączka K, Mądrzak L, Grymowicz M, Smolarczyk R. The Potential Health Risks and Benefits of Progesterone in the Transgender Woman Population—A Narrative Review. Journal of Clinical Medicine. 2024;13(22):6795. doi:10.3390/jcm13226795

BibTeX
@article{Szymczyk2024,
  author = {Szymczyk, Simone and Mączka, Katarzyna and Mądrzak, Lidia and Grymowicz, Monika and Smolarczyk, Roman},
  title = {The Potential Health Risks and Benefits of Progesterone in the Transgender Woman Population—A Narrative Review},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {22},
  pages = {6795},
  doi = {10.3390/jcm13226795}
}
Kostenlos starten →